MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

    R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…
  • 2025 International Congress

    Association between cognitive adverse effects of anticholinergic medication and development of long-term dementia in Parkinson’s disease

    SH. Ha, BR. Jin, SY. Kim, SM. Lee, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate whether cognitive adverse effects occurring immediately after taking anticholinergics are related to the development of long-term dementia and to interpret this from…
  • 2025 International Congress

    PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease

    JL. Li, CC. Chan, CH. Lin (New Taipei City, Taiwan)

    Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…
  • 2025 International Congress

    Moyamoya Disease and the Risk of Parkinson’s Disease

    D. Yoo, J. Shin, R. Lee, J. Cheon, J. Kim, J. Won, I. Oh, Y. Lee, T. Ahn (Suwon, Republic of Korea)

    Objective: We aimed to determine whether the risk of Parkinson’s disease (PD) is increased in patients with Moyamoya disease (MMD) and to identify the potential…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley